Program Description: 

Through its educational arm, the ISTH Academy, the International Society on Thrombosis and Haemostasis (ISTH) has begun hosting a series of webinars on practical thrombosis and haemostasis issues that scientists and physicians frequently confront. These webinars will allot time for participants to ask questions and will cover the latest information on relevant topics.


Join Maria Laura Bertolaccini and Bas de Laat for this webinar to learn about the diagnosis and management of antiphospholipid antibody syndrome. The diagnosis of the antiphospholipid syndrome is made on the basis of occurrence of thrombosis and the detection of antiphospholipid antibodies. As thrombosis has a high prevalence in the human population, the detection of antiphospholipid antibodies has to be accurate and precise. During this webinar, de Laat will discuss the detection of antiphospholipid antibodies in detail highlighting problems that one might face. Bertolaccini will discuss the treatment options after diagnosis. 

Part I: Detection
Bas de Laat, Maastricht University Medical Center (the Netherlands)


Part II: State of the Art Treatment
Maria Laura Bertolaccini, Kings College London (UK)


Gevorg Tamamyam, MD Anderson Cancer Center (USA) and Yerevan State Medical University (Armenia)

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
More information and online registration:

Sponsored by an unrestricted educational grant from Instrumentation Laboratory

Target audience: 
  • Clinical scientists
  • Clinical chemists
  • Scientists in the field of thrombosis
  • MD internal medicine
  • MD rheumatology
Learning objectives: 

At the conclusion of this activity, I will be able to:

  • Identify the laboratory criteria for the antiphospholipid syndrome
  • Apply the laboratory criteria for the antiphospholipid syndrome
  • Explain the pitfalls within the current laboratory criteria for the antiphospholipid syndrome
  • How can the current laboratory assays be improved; long term versus short term
  • Discuss treatment strategies in APS
  • Review potential new treatments for APS
Faculty & credentials: 
Planning Committee:
Yukio Ozaki
Geoff Barnes
Chris Ward
Cary Clark
Stephen Watson
  Maria Laura Bertolaccini             Bas de Laat
Gevorg Tamamyan
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  




Chris Ward, MD


Advisory Board, Speaker


Pfizer, BMS

Advisory Board, Speaker



Advisory Board, Speaker



Advisory Board



Steering Committee Member, Speaker

Geoff Barnes

BMS, Pfizer, Blue Cross Blue Shield of Michigan

Primary Investigator & Co-Investigator

Yukio Ozaki


Advisory Board

Bas de LaatDiagnostica StagoConsultant

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved






Cary Clark
Phone number: 
+1 (919) 929-3807
Session date: 
08/26/2015 - 12:00pm to 1:00pm CDT
ISTH Webinar Library Once a Month
Carrboro, NC 27510
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.